MedTrace Logo

Nocturnal Oxygen Therapy

NCT00000564 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2005-06-24

No results posted yet for this study

Summary

To compare the efficacy of long-term use of nocturnal oxygen therapy (12 hours) with that of continuous, low-flow oxygen therapy (24 hours) in patients with chronic hypoxic lung disease.

Conditions

Interventions

PROCEDURE

oxygen inhalation therapy

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Nicholas Anthonisen · University of Manitoba

  • C.Thomas Boylen · University of Southern California

  • David Cugell · Northwestern University

  • Paul Kvale · Henry Ford Hospital

  • Thomas Petty · University of Colorado, Denver

  • Richard Timms · University of California, San Diego

  • George Williams · The Cleveland Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1976-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000564 on ClinicalTrials.gov